Managing antifungal drugs for invasive aspergillosis in critically ill patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the current situation and outcomes of critically ill patients diagnosed with invasive aspergillus infection. By collecting and analyzing data on treatment approaches and patient responses, the study seeks to provide insights into the effectiveness of antifungal therapies in real-world settings. The focus is on understanding how these patients are managed and the results of their treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age\>18 year-old
* Diagosed as invasive aspergillus infection

Exclusion Criteria:

* Pregnant

Where it's running

• Southeast University, Zhongda hospital
  Nanjing, Jiangsu, China Recruiting

Study contacts

• Principal investigator: Jingyuan Xu, M.D. — Southeast University
• Study coordinator: Jingyuan Xu, M.D.
• Email: 13851417209@163.com
• Phone: 8613851417209

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Detecting azole resistance in invasive aspergillosis patients using blood samples

  This study is testing a new way to quickly find out if patients with a serious fungal infection have a type that is resistant to common treatments, using blood samples from people with weakened immune systems.

  Recruiting Erasmus Medical Center · Rotterdam, South Holland · NCT06069505

• Investigating how Posaconazole works in cancer patients receiving chemotherapy or stem cell transplants

  This study is testing how well the antifungal drug Posaconazole works in adults getting chemotherapy or stem cell transplants to see if it can help prevent serious fungal infections.

  Recruiting Phase 4 Melbourne Health · Parkville, Victoria · NCT03717623

• Understanding immune system issues that cause fungal infections

  This study is trying to learn more about why some people's immune systems cause severe fungal infections by collecting health information and samples from patients, their family members, and healthy volunteers.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT01386437

• PCR testing in blood and lung washings to monitor invasive pulmonary aspergillosis

  This will test whether repeated PCR tests for Aspergillus fumigatus in blood and bronchoalveolar lavage fluid can track treatment response in adults with invasive pulmonary aspergillosis.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07313527

• Breath analysis to detect fungal infections in leukemia patients

  This study is testing if analyzing breath samples can help doctors detect fungal infections in leukemia patients who are at high risk due to their treatment.

  Recruiting University of Zurich · Zurich, Canton of Zurich · NCT06537726

• Early diagnosis of invasive lung aspergillosis

  This study is trying to see if new tests can help doctors diagnose lung infections caused by fungus earlier in critically ill patients.

  Recruiting at 7 sites University Hospital Ostrava · Havířov, Moravian-Silesian Region and 6 other locations · NCT05860387

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.